CERTOLIZUMAB THERAPY IN REFRACTORY UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMID). MULTICENTER STUDY OF 39 PATIENTS

dc.conference.dateJUN 03, 2020
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorMartin-Varillas, J. L.
dc.contributor.authorCalvo-Rio, V.
dc.contributor.authorSanchez-Bilbao, L.
dc.contributor.authorGonzalez-Mazon, I.
dc.contributor.authorTorre-Salaberri, I.
dc.contributor.authorGarcia Martos, A.
dc.contributor.authorSanchez-Andrade, A.
dc.contributor.authorGarcia-Aparicio, A.
dc.contributor.authorDe Dios-Jimenez Aberasturi, J.
dc.contributor.authorUrruticoechea-Arana, A.
dc.contributor.authorMaiz, O.
dc.contributor.authorGonzalez, R. Veroz
dc.contributor.authorGarcia-Valle, A.
dc.contributor.authorRodriguez Montero, S.
dc.contributor.authorMiguelez, R.
dc.contributor.authorJovani, V.
dc.contributor.authorHernandez-Garfella, M.
dc.contributor.authorConesa, A.
dc.contributor.authorMartinez Gonzalez, O.
dc.contributor.authorRubio Munoz, P.
dc.contributor.authorAtienza-Mateo, B.
dc.contributor.authorGonzalez-Gay, M. A.
dc.contributor.authorBlanco, R.
dc.contributor.authoraffiliation[Martin-Varillas, J. L.] Hosp Sierrallana, Torrelavega, Spain
dc.contributor.authoraffiliation[Calvo-Rio, V.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Sanchez-Bilbao, L.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Gonzalez-Mazon, I.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Atienza-Mateo, B.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Gonzalez-Gay, M. A.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Blanco, R.] Hosp Univ M Valdecilla, Santander, Spain
dc.contributor.authoraffiliation[Torre-Salaberri, I.] Hosp Basurto, Bilbao, Spain
dc.contributor.authoraffiliation[Garcia Martos, A.] Hosp Tajo, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez-Andrade, A.] Hosp Lucus Augusti, Lugo, Spain
dc.contributor.authoraffiliation[Garcia-Aparicio, A.] Hosp Toledo, Toledo, Spain
dc.contributor.authoraffiliation[Miguelez, R.] Hosp Toledo, Toledo, Spain
dc.contributor.authoraffiliation[De Dios-Jimenez Aberasturi, J.] Hosp Alava, Alava, Spain
dc.contributor.authoraffiliation[Urruticoechea-Arana, A.] Hosp Can Misses, Ibiza, Spain
dc.contributor.authoraffiliation[Maiz, O.] Hosp Donosti, San Sebastian, Spain
dc.contributor.authoraffiliation[Gonzalez, R. Veroz] Hosp Merida, Merida, Spain
dc.contributor.authoraffiliation[Garcia-Valle, A.] Hosp Palencia, Palencia, Spain
dc.contributor.authoraffiliation[Rodriguez Montero, S.] Hosp Valme, Seville, Spain
dc.contributor.authoraffiliation[Jovani, V.] Hosp Alicante, Alicante, Spain
dc.contributor.authoraffiliation[Hernandez-Garfella, M.] Hosp G Valencia, Valencia, Spain
dc.contributor.authoraffiliation[Conesa, A.] Hosp Castellon, Castellon de La Plana, Spain
dc.contributor.authoraffiliation[Martinez Gonzalez, O.] Hosp Salamanca, Salamanca, Spain
dc.contributor.authoraffiliation[Rubio Munoz, P.] Hosp Esperit St, Barcelona, Spain
dc.date.accessioned2025-01-07T15:25:54Z
dc.date.available2025-01-07T15:25:54Z
dc.date.issued2020-06-01
dc.identifier.doi10.1136/annrheumdis-2020-eular.6367
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/79/Suppl_1/384.2.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/27144
dc.identifier.wosID555905001155
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de Valme
dc.page.number380-381
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleCERTOLIZUMAB THERAPY IN REFRACTORY UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMID). MULTICENTER STUDY OF 39 PATIENTS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number79
dc.wostypeMeeting Abstract

Files